Glenmark Pharmaceuticals Limited (NSE:GLENMARK)
India · Delayed Price · Currency is INR 1,880.60
+32.80 (1.78%)
Nov 13, 2025, 3:29 PM IST
Glenmark Pharmaceuticals Market Cap
Glenmark Pharmaceuticals has a market cap or net worth of 521.45 billion as of November 13, 2025. Its market cap has increased by 9.61% in one year.
Market Cap
521.45B
Enterprise Value
529.12B
Revenue
134.56B
Ranking
n/a
PE Ratio
69.21
Stock Price
1,880.60
Market Cap Chart
Since June 7, 2001, Glenmark Pharmaceuticals's market cap has increased from 1.15B to 521.45B, an increase of 45,271.02%. That is a compound annual growth rate of 28.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2025 | 521.45B | 14.84% |
| Dec 31, 2024 | 454.07B | 88.44% |
| Dec 29, 2023 | 240.96B | 101.33% |
| Dec 30, 2022 | 119.68B | -19.75% |
| Dec 31, 2021 | 149.14B | 7.10% |
| Dec 31, 2020 | 139.25B | 42.03% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.16T |
| Divi's Laboratories | 1.73T |
| Cipla | 1.23T |
| Apollo Hospitals Enterprise | 1.08T |
| Zydus Lifesciences | 957.33B |
| Mankind Pharma | 936.96B |
| Fortis Healthcare | 731.86B |
| Alkem Laboratories | 689.59B |